Control of hereditary diseases

World Health Organization - Technical Report Series

Volumn , Issue 865, 1996, Pages

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

EID: 17444449933     PISSN: 05123054     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (52)

1. McKusick VA. Mendelian inheritance in man, 10th ed. Baltimore, MD, Johns Hopkins University Press, 1994.
2. Forfar JO. Demography, vital statistics and the pattern of disease in childhood. In: Campbell AGM, McIntosh N, eds. Forfar and Arniel's textbook of paediatrics, 4th ed. Edinburgh, Churchill Livingstone, 1992.
3. Community approaches to the control of hereditary diseases. Report of a WHO Advisory Group on Hereditary Diseases. Geneva, World Health Organization, 1985 (unpublished document HMG/WG/85.10, available on request from Human Genetics, World Health Organization, 1211 Geneva 27, Switzerland).
4. Baird PA et al. Genetic disorders in children and young adults: a population study. American journal of human genetics, 1988, 42:677-693.
5. Czeizel A, Sankaranarayanan K. The load of genetic and partly genetic disorders in man. 1. Congenital anomalies: estimates of detriment in terms of years of life lost and years of impaired life. Mutation research, 1984, 128: 73-103.
6. Modell B, Kuliev AM, Wagner M. Community genetics services in Europe. Copenhagen, World Health Organization, Regional Office for Europe, 1992 (WHO Regional Publication, European Series No. 38).
7. Prevention and control of haemoglobinopathies. Report of a Joint WHO/Thalassaemia International Federation Meeting and 7th Meeting of the WHO Working Group on the Control of Hereditary Anaemias. Geneva, World Health Organization, 1993 (unpublished document WHO/HDP/TIF/HA/93.1, available on request from Human Genetics, World Health Organization, 1211 Geneva 27, Switzerland).
8. Glucose-6-phosphate dehydrogenase deficiency. Report of a WHO Working Group. Bulletin of the World Health Organization 1989, 67:601-611.
9. Guidelines for the control of haemoglobin disorders. Geneva, World Health Organization, 1994 (unpublished document WHO/HDP/HB/GL794.1, available on request from Human Genetics, World Health Organization, 1211 Geneva 27, Switzerland).
10. Bittles AH. Consanguineous marriage: current global incidence and its relevance to demographic research. Detroit, MI, Population Studies Center, University of Michigan, 1990 (Research Report No. 90-186).
11. Costa T, Scriver C, Childs B. The effect of Mendelian disease on human health: a measurement. American journal of medical genetics, 1985, 21:231-242.
12. Advances in diagnosis, treatment and prevention of hereditary diseases. Report of a World Health Organization meeting. Geneva, World Health Organization, 1989 (unpublished document WHO/HDP/ADV/89.3, available on request from Human Genetics, World Health Organization, 1211 Geneva 27, Switzerland).
13. Czeizel A, Intody Z, Modell B. What proportion of congenital anomalies can be prevented? British medical journal, 1993, 306:499-502.
14. de la Mata I et al. Incidence of congenital rubella syndrome in 19 regions of Europe in 1980-1986. European journal of epidemiology, 1989, 5:106-109.
15. MRC Vitamin Research Group. Prevention of neural tube defects: results of the Medical Research Council vitamin study. Lancet, 1991, 338:131-137.
16. Varekamp I et al. Carrier testing and prenatal diagnosis for hemophilia: experiences and attitudes of 549 potential and obligate carriers. American journal of medical genetics, 1990, 37:147-154.
17. Cuckle HS, Wald NJ. Principles of screening. In: NJ Wald, ed. Antenatal and neonatal screening. Oxford, Oxford University Press, 1984.
18. Kaback M et al. Tay-Sachs disease - carrier screening, prenatal diagnosis, and the molecular era. An international perspective 1970-1993. Journal of the American Medical Association, 1993, 270:2307-2315.
19. Stone MH et al. Comparison of audible sound transmission with ultrasound in screening for congenital dislocation of the hip. Lancet, 1990, 336:421-422.
20. Illig R et al. Mental development in congenital hypothyroidism after neonatal screening. Archives of disease in childhood, 1987, 62:1050-1055.
21. Neonatal screening for sickle cell disease. Paediatrics, 1989, 83 (Suppl.).
22. Balnaves ME et al. The impact of newborn screening on cystic fibrosis testing in Victoria, Australia. Journal of medical genetics, 1995, 32:537-542.
23. Smith RA et al. Screening for Duchenne muscular dystrophy. Archives of disease in childhood, 1989, 64:1017-1021.
24. Wald NJ et al. Antenatal maternal serum screening for Down's syndrome: results of a demonstration study. British medical journal, 1992, 305:391-393.
25. Canadian Royal Commission on New Reproductive Technologies. Proceed with care. Final report of the Canadian Royal Commission on New Reproductive Technologies, Vol. 2. Ottawa, Canada Communications Group - Publishing, 1993.
26. Czeizel AE. Prevention of congenital abnormalities by periconceptional multivitamin supplementation. British medical journal, 1993, 306:1645-8.
27. Craufurd D et al. Uptake of presymptomatic predictive testing for Huntington's disease. Lancet, 1989, ii:603-605.
28. Sangani B et al. Thalassaemia in Bombay: the role of medical genetics in developing countries. Bulletin of the World Health Organization, 1990, 68:75-81.
29. Fletcher JC, Berg K, Tranoy KE. Ethical aspects of medical genetics. A proposal for guidelines in genetic counselling, prenatal diagnosis and screening. Clinical genetics, 1985, 27:199-205.
30. Weaver DD. Catalogue of prenatally diagnosed conditions, 2nd ed. Baltimore, MD, Johns Hopkins University Press, 1992.
31. Tului L, Brambati B. Acceptance of first trimester prenatal diagnosis: analysis of the religious and socio-cultural characteristics. Rivista di ostetrica, ginecologia pratica e medicina perinatale, 1990, 5:129-137.
32. Milunsky A. Genetic disorders and the fetus, 3rd ed. Baltimore, MD Johns Hopkins University Press, 1992.
33. Luck CA. Value of routine ultrasound scanning at 19 weeks: a four-year study of 8849 deliveries. British medical journal, 1992, 304:1474-1476.
34. Ewigman B, LeFevre M, Hesser J. A randomised trial of routine prenatal ultrasound. Obstetrics and gynaecology, 1990, 76:189-194.
35. Byrne D et al. Randomized study of early amniocentesis versus chorionic villus sampling: a technical and cytogenetic comparison of 650 patients. Ultrasound obstetrics and gynecology, 1991, 1:235-240.
36. Canadian Collaborative CVS-Amniocentesis Clinical Trial Group. Multicentre randomised clinical trial of chorion villus sampling and amniocentesis. First report. Lancet, 1989, i:1-6.
37. Medical Research Council Working Party on the Evaluation of Chorion Villus Sampling. Medical Research Council European trial of chorion villus sampling. Lancet, 1991, 337:1491-1499.
38. Firth HV et al. Severe limb abnormalities after chorion villus sampling at 56-66 days' gestation. Lancet, 1991, 337:762-763.
39. Romero R, Ghidini A, Santolaya J. Fetal blood sampling. In: Milunsky A, ed. Genetic disorders and the fetus, 3rd ed. Baltimore, MD, Johns Hopkins University Press, 1992:649-682.
40. Bianchi DW et al. Erythroid-specific antibodies enhance detection of fetal nucleated erythrocytes in maternal blood. Prenatal diagnosis, 1993, 13:293-300.
41. American College of Obstetricians and Gynecologists. Management of isoimmunization in pregnancy. Technical bulletin, 1990, 148:1-6.
42. Touraine JL et al. In utero transplantation of hemopoietic stem cells in humans. Transplantation proceedings, 1991, 23:1706-1708.
43. Lewontin RC. The dream of the human genome. New York Times review, 1992, 28:31-40.
44. Nolan K, Swenson S. New tools, new dilemmas: genetic frontiers. Hastings Center report, 1988, 18:40-46.
45. Knoppers BM. Newborn screening and informed consent. In: Farriaux JP, Dhont JL, eds. Proceedings of the 9th International Symposium on Neonatal Screening, Lille, France. Amsterdam, Elsevier Excerpta Medica, 1994:15-24.
46. Knoppers BM, Chadwick R. The Human Genome Project: under an international legal and ethical microscope. Science, 1994, 265:2033-2034.
47. Committee of the Health Council of the Netherlands. Heredity: science and society. The Hague, Health Council of the Netherlands, 1989.
48. Kielstein R, Sass H-M. Right not to know or duty to know? Prenatal screening for polycystic renal disease. Journal of medical philosophy, 1992, 17:395-405.
49. Andrews LB. The double helix. Houston law review, 1992, 29(1):149-184.
50. R. v. Dyment, 2 SCR 417-442, 1988; Privacy Commissioner of Canada, Genetic Testing and Privacy, Minister of Supply and Services, 1992.
51. R. v. Dyment, 2 SCR 417-442, 1988; Privacy Commissioner of Canada, Genetic Testing and Privacy, Minister of Supply and Services, 1992.
52. Eisenberg RS. Patenting the human genome. Emory law journal, 1990, 39: 721-745.